Quick Facts
  • pin location icon
    Primary Location:
    Brigham and Women’s Hospital
  • wavy circle icon with check mark inside
    Expertise:
    Thoracic Malignancies
    Clinical Research
  • magnifying glass with heart icon
    Speciality:
    Thoracic Radiology
  • gender symbols interlocked icon
    Gender:
    Female
  • chat box with different language translations icon
    Language:
    English
  • certificate with a ribbon icon below
    Med School:
    Harvard Medical School

Radiation oncologist Dr. Elizabeth Baldini is part of the multidisciplinary team treating pleural mesothelioma at the Dana-Farber Cancer Institute and Brigham and Women’s Hospital in Boston.

She was board certified in 1993 after graduating from the Harvard Medical School, then doing her residency at the nearby Joint Center for Radiation Therapy. She completed her internship at Brigham and Women’s.

Baldini is involved in clinical research and the treatment of thoracic malignancies with a particular focus on mesothelioma. She has helped define new strategies for clinical management of soft tissue and bone sarcomas, stemming from her analysis of patterns of failure with various histologic subtypes.

In 2021, Baldini published research on radiation toxicity in patients with non-small cell lung cancer. Her work helped identify areas of improvement in radiotherapy safety for patients with thoracic cancers.

Contact Dr. Elizabeth Baldini
medical stethoscope icon
By submitting, you agree to our privacy policy and disclaimer. Our Patient Advocates may contact you via phone, email and/or text.

She was the lead author on a paper involving former mesothelioma program director Dr. David Sugarbaker and current director Dr. Raphael Bueno. The Journal of Thoracic and Cardiovascular Surgery published the study in 2015.

people watching webinar on computer
Browse Our Free Mesothelioma Webinars
group of people holding money
Access More than $32 Billion in Trust Funds
scientists in laboratory
Find Active Mesothelioma Clinical Trials